Figure 1 | Scientific Reports

Figure 1

From: Using OpenPrescribing.net to evaluate neighbourhood-level prescribing of inhalers for asthma and COPD

Figure 1

(A) Number of prescriptions dispensed in the month of March for England for the years 2017–2023 for key inhaler subsets. COVID-19 lockdown occurred in March 2020, resulting in extreme changes in prescribing behaviour. (B) Inhaler prescriptions dispensed in England month-by-month for the subsets in (A) along with some additional subsets, and national totals for all inhaler drugs and inhaler types. Dashed lines at national lockdowns. (C) Percentage increase in inhaler prescriptions dispensed in England from February to March 2020 for the categories displayed in (B) . DPI dry powder inhalers, ICS inhaled corticosteroid, LABA long-acting beta agonist, LAMA long-acting muscarinic antagonist, MDI metered-dose inhalers, SABA short-acting beta agonist.

Back to article page